Athersys Inc (ATHXQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Athersys Research and Development Expense (TTM): 29.98M for Sept. 30, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 29.98M |
| June 30, 2023 | 38.41M |
| March 31, 2023 | 48.55M |
| December 31, 2022 | 65.03M |
| September 30, 2022 | 72.88M |
| June 30, 2022 | 77.62M |
| March 31, 2022 | 74.52M |
| December 31, 2021 | 71.08M |
| September 30, 2021 | 71.02M |
| June 30, 2021 | 72.33M |
| March 31, 2021 | 68.41M |
| December 31, 2020 | 62.99M |
| September 30, 2020 | 51.97M |
| June 30, 2020 | 42.35M |
| March 31, 2020 | 39.72M |
| December 31, 2019 | 39.04M |
| September 30, 2019 | 41.58M |
| June 30, 2019 | 42.26M |
| March 31, 2019 | 41.22M |
| December 31, 2018 | 38.65M |
| September 30, 2018 | 40.62M |
| June 30, 2018 | 36.52M |
| March 31, 2018 | 31.06M |
| December 31, 2017 | 27.84M |
| September 30, 2017 | 22.80M |
| Date | Value |
|---|---|
| June 30, 2017 | 22.62M |
| March 31, 2017 | 23.81M |
| December 31, 2016 | 24.84M |
| September 30, 2016 | 23.05M |
| June 30, 2016 | 22.88M |
| March 31, 2016 | 22.31M |
| December 31, 2015 | 21.32M |
| September 30, 2015 | 21.63M |
| June 30, 2015 | 22.31M |
| March 31, 2015 | 22.81M |
| December 31, 2014 | 23.36M |
| September 30, 2014 | 22.87M |
| June 30, 2014 | 21.78M |
| March 31, 2014 | 21.13M |
| December 31, 2013 | 20.48M |
| September 30, 2013 | 20.31M |
| June 30, 2013 | 19.72M |
| March 31, 2013 | 19.64M |
| December 31, 2012 | 19.64M |
| September 30, 2012 | 20.27M |
| June 30, 2012 | 20.49M |
| March 31, 2012 | 19.91M |
| December 31, 2011 | 18.93M |
| September 30, 2011 | 17.57M |
| June 30, 2011 | 17.58M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
29.98M
Minimum
Sep 2023
77.62M
Maximum
Jun 2022
56.91M
Average
62.99M
Median
Dec 2020
Research and Development Expense (TTM) Benchmarks
| Ampio Pharmaceuticals Inc | 2.439M |
| FluoroPharma Medical Inc | 0.5551M |
| Evolutionary Genomics Inc | 0.4175M |
| MetaStat Inc | 1.451M |
| Xeno Transplants Corp | -- |